{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:59:40Z","timestamp":1793170780100,"version":"4.5.0"},"reference-count":74,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T00:00:00Z","timestamp":1601251200000},"content-version":"vor","delay-in-days":27,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:p>The pathogenesis of primary sclerosing cholangitis (PSC), a progressive biliary tract disease without approved medical therapy, is not well understood. The relationship between PSC and inflammatory bowel disease has inspired theories that intestinal factors may contribute to the development and progression of hepatobiliary fibrosis in PSC. There is evidence from both fecal and mucosa\u2010associated microbial studies that patients with PSC harbor an abnormal enteric microbiome. These organisms are thought to produce toxic byproducts that stimulate immune\u2010mediated damage of hepatocytes and the biliary tree. The link between these mechanisms may be related to altered intestinal permeability leading to migration of bacteria or associated toxins to the liver through the portal circulation. In support of these concepts, early trials have demonstrated improved biochemical parameters and symptoms of PSC with oral antibiotics, ostensibly through manipulation of the enteric microbiota. This article reviews the published literature for evidence as well as gaps in knowledge regarding these mechanisms by which intestinal aberrations might drive the development of PSC. We also identify areas of future research that are needed to link and verify these pathways to enhance diagnostic and therapeutic approaches.<\/jats:p>","DOI":"10.1002\/hep.31311","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T01:58:58Z","timestamp":1589248738000},"page":"1127-1138","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":49,"title":["The Role of the Intestine in the Pathogenesis of Primary Sclerosing Cholangitis: Evidence and Therapeutic Implications"],"prefix":"10.1097","volume":"72","author":[{"given":"Gregory","family":"Dean","sequence":"first","affiliation":[{"name":"Department of Internal Medicine,Northwestern University Feinberg School of Medicine,Chicago,IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Hanauer","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Department of Internal Medicine,Northwestern University Feinberg School of Medicine,Chicago,IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Levitsky","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Department of Internal Medicine,Northwestern University Feinberg School of Medicine,Chicago,IL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,9,28]]},"reference":[{"key":"hep31311-bib-0001-20241017","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","year":"2017","journal-title":"Gastroenterology"},{"key":"hep31311-bib-0002-20241017","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC\u2010IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","year":"2005","journal-title":"Gut"},{"key":"hep31311-bib-0003-20241017","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00281-009-0154-7","article-title":"The immunobiology of primary sclerosing cholangitis","volume":"31","year":"2009","journal-title":"Semin Immunopathol"},{"key":"hep31311-bib-0004-20241017","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrgastro.2016.154","article-title":"Genetics of primary sclerosing cholangitis and pathophysiological implications","volume":"14","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"hep31311-bib-0005-20241017","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1053\/jlts.2003.50143","article-title":"Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation","volume":"9","year":"2003","journal-title":"Liver Transpl"},{"key":"hep31311-bib-0006-20241017","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00431-014-2476-2","article-title":"The intestinal microbiota: its role in health and disease","volume":"174","year":"2015","journal-title":"Eur J Pediatr"},{"key":"hep31311-bib-0007-20241017","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/hep.1840130425","article-title":"Biliary tract disease in rats with experimental small bowel bacterial overgrowth","volume":"13","year":"1991","journal-title":"Hepatology"},{"key":"hep31311-bib-0008-20241017","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0016-5085(91)90224-9","article-title":"Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline","volume":"100","year":"1991","journal-title":"Gastroenterology"},{"key":"hep31311-bib-0009-20241017","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","article-title":"The microbiome in inflammatory bowel disease: current status and the future ahead","volume":"146","year":"2014","journal-title":"Gastroenterology"},{"key":"hep31311-bib-0010-20241017","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.3748\/wjg.v23.i25.4548","article-title":"Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis","volume":"23","year":"2017","journal-title":"World J Gastroenterol"},{"key":"hep31311-bib-0011-20241017","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1136\/gutjnl-2016-312533","article-title":"Characterisation of the faecal microbiota in Japanese patients with paediatric\u2010onset primary sclerosing cholangitis","volume":"66","year":"2017","journal-title":"Gut"},{"key":"hep31311-bib-0012-20241017","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/gutjnl-2015-310500","article-title":"The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls","volume":"66","year":"2017","journal-title":"Gut"},{"key":"hep31311-bib-0013-20241017","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/gutjnl-2018-317791","article-title":"Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis","volume":"69","year":"2020","journal-title":"Gut"},{"key":"hep31311-bib-0014-20241017","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41564-018-0333-1","article-title":"Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis","volume":"4","year":"2019","journal-title":"Nat Microbiol"},{"key":"hep31311-bib-0015-20241017","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/apt.15375","article-title":"Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis","volume":"50","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31311-bib-0016-20241017","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","article-title":"Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD","volume":"65","year":"2016","journal-title":"Gut"},{"key":"hep31311-bib-0017-20241017","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/2050640617708953","article-title":"The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease","volume":"6","year":"2018","journal-title":"United European Gastroenterol J"},{"key":"hep31311-bib-0018-20241017","first-page":"386","article-title":"The gut\u2010adherent microbiota of PSC\u2010IBD is distinct to that of IBD","volume":"66","year":"2017","journal-title":"Gut"},{"key":"hep31311-bib-0019-20241017","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/apt.13552","article-title":"The features of mucosa\u2010associated microbiota in primary sclerosing cholangitis","volume":"43","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31311-bib-0020-20241017","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/ecco-jcc\/jjv204","article-title":"Characterization of intestinal microbiota in ulcerative colitis patients with and without primary sclerosing cholangitis","volume":"10","year":"2016","journal-title":"J Crohns Colitis"},{"key":"hep31311-bib-0021-20241017","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/ecco-jcc\/jju023","article-title":"The mucosa\u2010associated microbiota of PSC patients is characterized by low diversity and low abundance of uncultured Clostridiales II","volume":"9","year":"2015","journal-title":"J Crohns Colitis"},{"key":"hep31311-bib-0022-20241017","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1053\/j.gastro.2011.05.035","article-title":"Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation","volume":"141","year":"2011","journal-title":"Gastroenterology"},{"key":"hep31311-bib-0023-20241017","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1046\/j.1365-2249.2003.02166.x","article-title":"Anti\u2010Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases","volume":"132","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"hep31311-bib-0024-20241017","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-0035-1571276","article-title":"Targeting dysbiosis for the treatment of liver disease","volume":"36","year":"2016","journal-title":"Semin Liver Dis"},{"key":"hep31311-bib-0025-20241017","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-4615-4143-1_2","article-title":"Bacterial translocation from the gastrointestinal tract","volume":"473","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"hep31311-bib-0026-20241017","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1136\/gut.2005.085373","article-title":"Alterations in intestinal permeability","volume":"55","year":"2006","journal-title":"Gut"},{"key":"hep31311-bib-0027-20241017","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12876-014-0189-7","article-title":"Intestinal permeability\u2014a new target for disease prevention and therapy","volume":"14","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"hep31311-bib-0028-20241017","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0016-5085(98)70636-5","article-title":"Discrimination of site\u2010specific alterations in gastrointestinal permeability in the rat","volume":"114","year":"1998","journal-title":"Gastroenterology"},{"key":"hep31311-bib-0029-20241017","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1749-6632.2012.06612.x","article-title":"Abnormal intestinal permeability in Crohn's disease pathogenesis","volume":"1258","year":"2012","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl. 1","key":"hep31311-bib-0030-20241017","first-page":"S707","article-title":"Comparison of small bowel and colonic mucosal permeability in ulcerative\/microscopic colitis, irritable bowel syndrome\u2010diarrhea, and healthy controls by urinary saccharide excretion measurements","volume":"140","year":"2011","journal-title":"Gastroenterology"},{"key":"hep31311-bib-0031-20241017","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1002\/ibd.22909","article-title":"Increased small intestinal permeability in ulcerative colitis: rather genetic than environmental and a risk factor for extensive disease?","volume":"18","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"hep31311-bib-0032-20241017","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0016-5085(98)70137-4","article-title":"In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis","volume":"115","year":"1998","journal-title":"Gastroenterology"},{"key":"hep31311-bib-0033-20241017","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/00006231-200109000-00009","article-title":"(51)CrEDTA colonic permeability and therapy response in patients with ulcerative colitis","volume":"22","year":"2001","journal-title":"Nucl Med Commun"},{"key":"hep31311-bib-0034-20241017","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/gut.34.4.509","article-title":"Increased absorption of polyethylene glycol 600 deposited in the colon in active ulcerative colitis","volume":"34","year":"1993","journal-title":"Gut"},{"key":"hep31311-bib-0035-20241017","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1080\/00365520510023288","article-title":"Intestinal permeability and bacterial growth of the small bowel in patients with primary sclerosing cholangitis","volume":"40","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"hep31311-bib-0036-20241017","doi-asserted-by":"crossref","first-page":"780\u2010","DOI":"10.1093\/ibd\/izz211","article-title":"Is ulcerative colitis associated with primary sclerosing cholangitis an undertreated condition?","volume":"26","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"hep31311-bib-0037-20241017","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A re\u2010evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts","volume":"15","year":"2009","journal-title":"Liver Transpl"},{"key":"hep31311-bib-0038-20241017","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00042737-200601000-00012","article-title":"The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis","volume":"18","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"hep31311-bib-0039-20241017","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0168-8278(98)80316-4","article-title":"Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers","volume":"28","year":"1998","journal-title":"J Hepatol"},{"key":"hep31311-bib-0040-20241017","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/gutjnl-2019-318416","article-title":"Alterations of the bile microbiome in primary sclerosing cholangitis","volume":"69","year":"2020","journal-title":"Gut"},{"key":"hep31311-bib-0041-20241017","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0168-8278(91)90933-3","article-title":"Plasma endotoxin concentrations in patients with alcoholic and non\u2010alcoholic liver disease: reevaluation with an improved chromogenic assay","volume":"12","year":"1991","journal-title":"J Hepatol"},{"key":"hep31311-bib-0042-20241017","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hep.28853","article-title":"Low\u2010grade endotoxemia and platelet activation in cirrhosis","volume":"65","year":"2017","journal-title":"Hepatology"},{"key":"hep31311-bib-0043-20241017","first-page":"459","article-title":"Small bowel bacterial overgrowth and endotoxemia in cirrhosis","volume":"41","year":"2002","journal-title":"Chin J Intern Med"},{"key":"hep31311-bib-0044-20241017","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0168-8278(00)80242-1","article-title":"Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol\u2010induced liver disease","volume":"32","year":"2000","journal-title":"J Hepatol"},{"key":"hep31311-bib-0045-20241017","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/0016-5085(88)90560-4","article-title":"Enterohepatic circulation of bacterial chemotactic peptide in rats with experimental colitis","volume":"94","year":"1988","journal-title":"Gastroenterology"},{"key":"hep31311-bib-0046-20241017","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/BF02365447","article-title":"Small duct cholangitis induced by N\u2010formyl L\u2010methionine L\u2010leucine L\u2010tyrosine in rats","volume":"29","year":"1994","journal-title":"J Gastroenterol"},{"key":"hep31311-bib-0047-20241017","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.3390\/ijms19103003","article-title":"Inflammation and the gut\u2010liver axis in the pathophysiology of cholangiopathies","volume":"19","year":"2018","journal-title":"Int J Mol Sci"},{"key":"hep31311-bib-0048-20241017","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1111\/j.1478-3231.2011.02635.x","article-title":"Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis","volume":"31","year":"2011","journal-title":"Liver Int"},{"key":"hep31311-bib-0049-20241017","doi-asserted-by":"crossref","first-page":"G1077","DOI":"10.1152\/ajpgi.00227.2012","article-title":"Advances in cholangiocyte immunobiology","volume":"303","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"hep31311-bib-0050-20241017","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/hep.26993","article-title":"Cholangiocyte senescence by way of N\u2010ras activation is a characteristic of primary sclerosing cholangitis","volume":"59","year":"2014","journal-title":"Hepatology"},{"key":"hep31311-bib-0051-20241017","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/hep.26447","article-title":"Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis","volume":"58","year":"2013","journal-title":"Hepatology"},{"key":"hep31311-bib-0052-20241017","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/gut.49.1.131","article-title":"Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis","volume":"49","year":"2001","journal-title":"Gut"},{"key":"hep31311-bib-0053-20241017","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1053\/j.gastro.2012.07.031","article-title":"Th17 cells regulate liver fibrosis by targeting multiple cell types: many birds with one stone","volume":"143","year":"2012","journal-title":"Gastroenterology"},{"key":"hep31311-bib-0054-20241017","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.phrs.2015.12.007","article-title":"Pharmacology of bile acid receptors: evolution of bile acids from simple detergents to complex signaling molecules","volume":"104","year":"2016","journal-title":"Pharmacol Res"},{"key":"hep31311-bib-0055-20241017","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut\u2010liver axis and the intersection with the microbiome","volume":"15","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"hep31311-bib-0056-20241017","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.tips.2015.08.002","article-title":"TGR5 and Immunometabolism: insights from physiology and pharmacology","volume":"36","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"hep31311-bib-0057-20241017","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MOG.0000000000000057","article-title":"Bile acids and the gut microbiome","volume":"30","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"key":"hep31311-bib-0058-20241017","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nri1784","article-title":"Aberrant homing of mucosal T cells and extra\u2010intestinal manifestations of inflammatory bowel disease","volume":"6","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"hep31311-bib-0059-20241017","doi-asserted-by":"crossref","first-page":"e276","DOI":"10.2741\/A923","article-title":"The role of cholangiocytes in the development of chronic inflammatory liver disease","volume":"7","year":"2002","journal-title":"Front Biosci"},{"key":"hep31311-bib-0060-20241017","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/BF02237304","article-title":"Cytokine production from colonic T cells in patients with ulcerative colitis with and without primary sclerosing cholangitis","volume":"41","year":"1998","journal-title":"Dis Colon Rectum"},{"key":"hep31311-bib-0061-20241017","first-page":"250","article-title":"Phenotypic and functional characteristics of colonic lymphocytes isolated from patients with primary sclerosing cholangitis and inflammatory bowel disease","volume":"42","year":"1995","journal-title":"Hepatogastroenterology"},{"key":"hep31311-bib-0062-20241017","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/ecco-jcc\/jjx050","article-title":"Th1 and innate lymphoid cells accumulate in primary sclerosing cholangitis\u2010associated inflammatory bowel disease","volume":"11","year":"2017","journal-title":"J Crohns Colitis"},{"key":"hep31311-bib-0063-20241017","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng.3745","article-title":"Genome\u2010wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease","volume":"49","year":"2017","journal-title":"Nat Genet"},{"key":"hep31311-bib-0064-20241017","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jhep.2012.10.013","article-title":"Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis","volume":"58","year":"2013","journal-title":"J Hepatol"},{"key":"hep31311-bib-0065-20241017","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.cgh.2012.12.032","article-title":"Association between reduced levels of alkaline phosphatase and survival times of patients with primary sclerosing cholangitis","volume":"11","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep31311-bib-0066-20241017","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/apt.12232","article-title":"Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis\u2014a pilot study","volume":"37","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"hep31311-bib-0067-20241017","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MPG.0b013e31816fee95","article-title":"Long\u2010term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic","volume":"47","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"hep31311-bib-0068-20241017","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1177\/039463200702000423","article-title":"Azithromycin may reduce cholestasis in primary sclerosing cholangitis: a case report and serendipitous observation","volume":"20","year":"2007","journal-title":"Int J Immunopathol Pharmacol"},{"key":"hep31311-bib-0069-20241017","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2180-8-39","article-title":"Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low\u2010level vancomycin resistance during persistent methicillin\u2010resistant Staphylococcus aureus bacteraemia","volume":"8","year":"2008","journal-title":"BMC Microbiol"},{"key":"hep31311-bib-0070-20241017","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s11011-018-0266-7","article-title":"Antibiotics protect against EAE by increasing regulatory and anti\u2010inflammatory cells","volume":"33","year":"2018","journal-title":"Metab Brain Dis"},{"key":"hep31311-bib-0071-20241017","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10875-012-9801-1","article-title":"Immunomodulatory effect of vancomycin on Treg in pediatric inflammatory bowel disease and primary sclerosing cholangitis","volume":"33","year":"2013","journal-title":"J Clin Immunol"},{"issue":"Suppl.","key":"hep31311-bib-0072-20241017","first-page":"S539","article-title":"Fecal microbiota transplantation improves microbiome diversity and liver enzyme profile in primary sclerosing cholangitis","volume":"112","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"hep31311-bib-0073-20241017","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/MEG.0b013e3282f5197e","article-title":"Probiotics in primary sclerosing cholangitis: a randomized placebo\u2010controlled crossover pilot study","volume":"20","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"hep31311-bib-0074-20241017","first-page":"CD003626","article-title":"Bile acids for primary sclerosing cholangitis","year":"2011","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.31311","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep.31311","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hep.31311","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1002\/hep.31311","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T20:51:50Z","timestamp":1729198310000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1002\/hep.31311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.31311","relation":{},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"value":"0270-9139","type":"print"},{"value":"1527-3350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"2020-03-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}